from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2164c/-

LFCtreatmentdescriptionclass of inhibitor

0.099

Amikacinug/mL Amikacintranslation

-0.893

Cap5-10ug/mL Capreomycintranslation

-1.341

Rox10-50 ug/mL Roxithromycintranslation

-0.211

SM2-5 ug/mL Streptomycintranslation

1.078

Tet5-10 ug/mL Tetracyclinetranslation

-0.096

Rif0.2-5ug/mL Rifampicintranscription

-0.514

Rifp0.1-0.5ug/mL Rifapentinetranscription

-3.397

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.970

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.820

CPZ10-50 ug/mL Chlorpromazinerespiration

0.741

Clofazimine10-13 ug/mL Clofaziminerespiration

0.103

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.670

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.280

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.320

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.176

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.234

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.075

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.317

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.869

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.008

KCN5-20 ug/mL Potassium cyaniderespiration

0.135

NaN30.2-2 mM Sodium aziderespiration

-1.329

Nigericin50 uM Nigericinrespiration

0.070

TRC10-150 ug/mL Triclosanrespiration

0.637

TRZ10-25 ug/mL Thioridazinerespiration

0.286

Valinomycin0.5-10 uM Valinomycinrespiration

0.773

ZnSO42 mM ZnSO4respiration

-0.299

menadione6-10 ug/mL Menadionerespiration

0.403

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.364

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.647

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.216

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.143

NRP_1Non-replicating persistence stage 1dosRassociated

-0.504

Amp0.2mg/mL AmpicillincellWall

0.943

Cephalexin20-100 ug/mL CephalexincellWall

-0.301

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.841

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.018

EMB10-20 ug/mL EthambutolcellWall

-0.086

Eta12-40 ug/mL EthionamidecellWall

-0.065

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.162

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.207

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.019

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.368

BZA0.12 mg/mL BenzamidearomaticAmides

-0.434

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.028

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.184

H2O24 mM hydrogen peroxideDNAdamaging

-0.238

Levo10 ug/mL LevofloxacinDNAdamaging

-0.677

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.110

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.257

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.810

UVUV-irradiationDNAdamaging

-0.202

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.839

Antimycin12.5-50 ug/mL Antimycin A?

-0.191

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.176

PA_110-50 ug/mL Antitubercular compound PA-1?

0.316

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.890

PA8240.2-2 ug/mL PA-824?

0.940

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.365

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.525

Verapamil50 uM Verapamil?

-0.346

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.529

methoxatin10-20 ug/mL Methoxatin?